CD109 Molecule (CD109) ELISA Kits

CD109 encodes a member of the alpha2-macroglobulin/complement superfamily. Additionally we are shipping CD109 Antibodies (131) and CD109 Proteins (7) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
CD109 235505 Q8R422
CD109 135228 Q6YHK3
CD109 363104  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top CD109 ELISA Kits at

Showing 10 out of 31 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Supplier Delivery Price Details
Human 0.057 ng/mL 0.15-10 ng/mL 96 Tests Log in to see 13 to 16 Days
Mouse 1.56 ng/mL 400-6.25 ng/mL   96 Tests Log in to see 15 to 18 Days
Rat 0.938 ng/mL 1.563-100 ng/mL   96 Tests Log in to see 12 to 14 Days
Rabbit 9.375 ng/mL 15.625-1000 ng/mL   96 Tests Log in to see 12 to 14 Days
Guinea Pig 1.875 ng/mL 3.125-200 ng/mL   96 Tests Log in to see 12 to 14 Days
Chicken 9.375 ng/mL 15.625-1000 ng/mL   96 Tests Log in to see 12 to 14 Days
Monkey 0.188 ng/mL 0.313-20 ng/mL   96 Tests Log in to see 12 to 14 Days
Pig 0.188 ng/mL 0.313-20 ng/mL   96 Tests Log in to see 12 to 14 Days
  96 Tests Log in to see 15 to 18 Days
  96 Tests Log in to see 15 to 18 Days

More ELISA Kits for CD109 Interaction Partners

Mouse (Murine) CD109 Molecule (CD109) interaction partners

  1. platelet and endothelial GARP (show LRRC32 ELISA Kits) are not important in hemostasis and thrombosis in mice

  2. Small-scale in vivo screening identified several genes, including Cd109, that encode novel pro-metastatic factors. We uncovered signaling mediated by Janus kinases (Jaks) and the transcription factor Stat3 (show STAT3 ELISA Kits) as a critical, pharmacologically targetable effector of CD109-driven lung cancer metastasis

  3. CD109 differentially regulates TGF-beta (show TGFB1 ELISA Kits)-induced ALK1 (show ACVRL1 ELISA Kits)-Smad1 (show SMAD1 ELISA Kits)/5 versus ALK5 (show TGFBR1 ELISA Kits)-Smad2 (show SMAD2 ELISA Kits)/3 pathways, leading to decreased extracellular matrix production in the skin; epidermal CD109 expression regulates dermal function through a paracrine mechanism

  4. the GARP (show LRRC32 ELISA Kits)/LTGF-beta1 complex on Treg cells is a major source of TGF-beta1 (show TGFB1 ELISA Kits) needed for induction of pTreg cells during the process of oral tolerance.

  5. GP96 (show HSP90B1 ELISA Kits) serves as an essential chaperone for the cell-surface protein (show CD28 ELISA Kits) glycoprotein A repetitions predominant (GARP (show LRRC32 ELISA Kits)), which is a docking receptor for latent membrane-associated TGF-beta (show TGFB1 ELISA Kits) (mLTGF-beta).

  6. CD109 decreases extracellular matrix production and fibrotic responses during hypoxic wound healing

  7. CD109 is present in serum as a soluble form, and suggest its potential as a novel tumor marker in patients with cancers that express CD109.

  8. CD109 might be an important regulator of osteoclastogenesis.

  9. findings demonstrate that CD109 overexpression in the epidermis reduces inflammation and granulation tissue area and improves collagen organization in vivo.

  10. Induction of both Th17-producing cells and Tregs is caused preferentially by Tregs expressing the latent TGF-beta1 (show TGFB1 ELISA Kits)/GARP (show LRRC32 ELISA Kits) complex on their cell surface rather than by secreted latent TGF-beta1 (show TGFB1 ELISA Kits).

Human CD109 Molecule (CD109) interaction partners

  1. The CD109 protein was up-regulated in hepatocellular carcinoma tissue compared with adjacent noncancerous tissue. CD109 shRNA knockdown delayed the G1-S phase transition, abrogated cell proliferation, and increased cell apoptosis. Furthermore, CD109 impaired TGF-beta (show TGFB1 ELISA Kits)/Smad (show SMAD1 ELISA Kits) signaling through control of p-smad2 (show SMAD2 ELISA Kits).

  2. CD109 is a putative biomarker for identifying a high-risk group among DLBCL patients.

  3. The most common HPA (show HPSE ELISA Kits) genotypes among Saudis were HPA-1 (show HPSE ELISA Kits) a + b- (75%), HPA-2 (show HPSE2 ELISA Kits) a + b- (62%), HPA-3 a + b- (51.5%), HPA (show HPSE ELISA Kits)-4 a + b- (99%), HPA-5 (show ITGA2 ELISA Kits) a + b- (76.5%), HPA (show HPSE ELISA Kits)-6 a + b- (100%) and HPA (show HPSE ELISA Kits)-15 a + b + (50%). The prevalent allele among the HPA (show HPSE ELISA Kits) systems was (a), except in the HPA (show HPSE ELISA Kits)-15 system where the (b) allele was found in 52% of the subjects.

  4. Expression levels of CD109 was reduced significantly in psoriasis. Lower expression of CD109 and TGF-beta (show TGFB1 ELISA Kits) RI was highly correlated with higher expression of Smad7 (show SMAD7 ELISA Kits) and Ki67 (show MKI67 ELISA Kits), suggesting that CD109 may induce the pathogenesis of psoriasis through Smad7 (show SMAD7 ELISA Kits)-mediated degradation of TGF-beta (show TGFB1 ELISA Kits) RI.

  5. sCD109 can bind TGF-beta (show TGFB1 ELISA Kits), inhibit TGF-beta (show TGFB1 ELISA Kits) binding to its receptors and decrease TGF-beta (show TGFB1 ELISA Kits) signalling and TGF-beta (show TGFB1 ELISA Kits)-induced cellular responses.

  6. These findings indicate that CD109 is an exosomal protein and that the C-terminal region of CD109 is required for its presence in the exosome.

  7. CD109 may be a potential pathology marker for gallbladder squamous cell/adenosquamous carcinomas.

  8. CD109 is specifically expressed in endothelial cells of cutaneous cavernous haemangioma.

  9. The results suggest that circulating endothelial cells express CD109 and represent a rare population of circulating tumor endothelial cells, that play a potentially useful prognostic role in patients with glioblastoma.

  10. CD109 overexpression was significantly associated with surgical stage, distant metastasis, and poor prognosis in myxofibrosarcoma.

CD109 Antigen Profile

Antigen Summary

This gene encodes a member of the alpha2-macroglobulin/complement superfamily. The encoded GPI-linked glycoprotein is found on the cell surface of platelets, activated T-cells, and endothelial cells. The protein binds to and negatively regulates signaling of transforming growth factor beta (TGF-beta). Multiple transcript variants encoding different isoforms have been found for this gene.

Gene names and symbols associated with CD109 Molecule (CD109) ELISA Kits

  • CD109 molecule (CD109) antibody
  • CD109 molecule (cd109) antibody
  • CD109 antigen (Cd109) antibody
  • CD109 molecule (Cd109) antibody
  • 9930012E15Rik antibody
  • AI480638 antibody
  • CD109 antibody
  • CPAMD7 antibody
  • GARP antibody
  • RP11-525G3.1 antibody

Protein level used designations for CD109 Molecule (CD109) ELISA Kits

CD109 molecule , CD109 antigen-like , GPI-anchored alpha 2 macroglobulin-related protein , GPI-anchored alpha-2 macroglobulin-related protein , Gov platelet alloantigens , 150 kDa TGF-beta-1-binding protein , C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7 , CD109 antigen , activated T-cell marker CD109 , p180 , platelet-specific Gov antigen , r150

100068163 Equus caballus
421862 Gallus gallus
462825 Pan troglodytes
569058 Danio rerio
100385557 Callithrix jacchus
100471342 Ailuropoda melanoleuca
100486953 Xenopus (Silurana) tropicalis
235505 Mus musculus
135228 Homo sapiens
474970 Canis lupus familiaris
100155478 Sus scrofa
534043 Bos taurus
363104 Rattus norvegicus
Selected quality suppliers for CD109 (CD109) ELISA Kits
Did you look for something else?